Ketamine plus therapy for depression with suicidal thoughts
Treatments studied
Part of Mental health clinical trials.
This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–70
- Diagnosed with borderline personality disorder (a pattern of unstable relationships and self-image)
- Diagnosed with depression or bipolar disorder that is currently moderate to severe
- Have had significant suicidal thoughts in the past two weeks
- Have tried at least two different antidepressant medications without adequate improvement
- Willing to commit to 6 months of DBT (dialectical behavior therapy, a structured weekly therapy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This study tests whether repeated ketamine infusions can reduce symptoms of severe borderline personality disorder, such as emotional instability and impulsivity. It is designed for people who have not improved enough with their current treatments.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.
Hear when a new Treatment-Resistant Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.